BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 21310382)

  • 1. Bilateral irreversible severe vision loss from cosmetic iris implants.
    George MK; Tsai JC; Loewen NA
    Am J Ophthalmol; 2011 May; 151(5):872-875.e1. PubMed ID: 21310382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveitis-glaucoma-hyphema syndrome and corneal decompensation in association with cosmetic iris implants.
    Arthur SN; Wright MM; Kramarevsky N; Kaufman SC; Grajewski AL
    Am J Ophthalmol; 2009 Nov; 148(5):790-3. PubMed ID: 19660735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious ocular complications of cosmetic iris implants in 14 eyes.
    Hoguet A; Ritterband D; Koplin R; Wu E; Raviv T; Aljian J; Seedor J
    J Cataract Refract Surg; 2012 Mar; 38(3):387-93. PubMed ID: 22244609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for ahmed glaucoma valve implantation in neovascular glaucoma: a case report.
    Sothornwit N
    J Med Assoc Thai; 2008; 91 Suppl 1():S162-5. PubMed ID: 18672609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy.
    Park UC; Park KH; Kim DM; Yu HG
    J Glaucoma; 2011 Sep; 20(7):433-8. PubMed ID: 20852440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular neovascularization associated with central and hemicentral retinal vein occlusion.
    Hayreh SS; Zimmerman MB
    Retina; 2012 Sep; 32(8):1553-65. PubMed ID: 22495331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
    Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
    J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM; Radwan A; el-Manawy W; el-Hawary I
    Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
    Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
    J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S; Buchacra O; Milla E; Andreu D; Tellez J
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-slice technique for the explantation of complicated BrightOcular© cosmetic iris implants.
    Shalash A; El Bahrawy M
    Int Ophthalmol; 2020 Jun; 40(6):1565-1570. PubMed ID: 32166580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage.
    Chuang LH; Wang NK; Chen YP; Yeung L; Hwang YS; Chen KJ; Wu WC; Chen TL; Lai CC
    Retina; 2013 Apr; 33(4):798-802. PubMed ID: 23114407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-matched comparison of vitrectomy, peripheral retinal endolaser, and endocyclophotocoagulation versus standard care in neovascular glaucoma.
    Marra KV; Wagley S; Omar A; Kinoshita T; Kovacs KD; Silva P; Kuperwaser MC; Arroyo JG
    Retina; 2015 Jun; 35(6):1072-83. PubMed ID: 25621944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by Ahmed valve implantation in neovascular glaucoma.
    Mahdy RA; Nada WM; Fawzy KM; Alnashar HY; Almosalamy SM
    J Glaucoma; 2013 Dec; 22(9):768-72. PubMed ID: 22790513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.